Table 3.

Baseline performance of treatment group compared to control group

Outcome measures	Treatmenta (n=6)	Controla (n=5)	U	z	P-value	rb
ERT	47	52	9	−1.10	0.31	−0.33
TASIT-NL	49	52	11	−0.74	0.50	−0.22
SIT	12.5	13	11.5	−0.65	0.54	−0.20
BVAQ	119	104	12	−0.55	0.62	−0.17
DEX-SC	9	7	9.5	−1.02	0.37	−0.31
Stroop CWT processing speed	55.5	48.5	12	−0.55	0.66	−0.17
Stroop CWT inhibition	1.75	1.59	6	−1.64	0.13	−0.49
Adapted MSET	18.5	15	11.5	−0.64	0.57	−0.19
SIB distress	109	117	11	−0.31	0.84	−0.09
SCL-90-R anxiety	17.5	12	9	−1.10	0.32	−0.33
SCL-90-R depression	28	22	11	−0.73	0.51	−0.22
Quality of life	12.5	16	9	−1.11	0.33	−0.33
Self-efficacy	36	39	9.5	−1.01	0.35	−0.30

Note:

^aMedians;

^beffect size.

Abbreviations: BVAQ, Bermond -Vorst Alexithymia Questionnaire; CWT, color-word test; DEX-SC, Dysexecutive Questionnaire – social conventions; ERT, Emotion Recognition Task; MSET, modified six-elements test; SCL-90-R, Symptom Checklist 90, revised; SIB, Scale for Interpersonal Behavior; SIT, social interpretation test; TASIT-NL, The Awareness of Social Inference Test (Dutch version).